GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FUT7, HMGCR, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
9.90028 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP3, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR |
9.43376 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TYR, XDH |
9.23468 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TYR, XDH |
8.83506 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, FUT7, GLO1, HMGCR, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
8.83506 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR |
8.36006 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, ALPI, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, FABP3, FABP4, FUT7, HMGCR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.98549 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR |
7.98039 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
7.57774 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGS2, SRC |
7.48912 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
7.41586 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.41586 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.99051 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SRC, TOP2A, TYR |
6.97104 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
6.70879 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HTR1A, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SRC, XDH |
6.65684 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TYR |
6.37927 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP4, HMGCR, HSD17B2, HTR1A, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR |
6.3575 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.2932 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, PTGS2, RORC, SRC, TYR |
6.24988 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FLT3, PTGS2, RORC, SRC, TYR |
6.22558 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, EPHX2, HMGCR, KDR, SRC |
6.22558 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
5.89049 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
5.81241 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.62795 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, DRD2, EPHX2, FLT3, HMGCR, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
5.62795 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CYP1B1, DRD2, ESR1, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, XDH |
5.43863 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.39558 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.3751 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EPHX2, PTGS1, PTGS2 |
5.35355 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
5.35355 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, DRD2, EPHX2, FLT3, HMGCR, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
5.33424 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, PTGS1, PTGS2 |
5.33424 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
5.33424 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, DRD2, ESR1, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2 |
5.2379 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
5.1757 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, PTGS1, PTGS2 |
5.15623 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PIK3CA, PTGS2, RORC, SRC |
5.09766 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CYP1A2, ESR1, FABP3, FLT3, PPARA, PTGS2, SRC |
4.99932 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HMGCR, HSD17B2 |
4.97221 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EPHX2, NQO2, PTGS1, RORC |
4.92142 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, RORC, SRC, TOP2A |
4.85417 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.7464 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CYP1A2, ESR1, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC |
4.71347 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC |
4.61282 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.51671 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD2, FABP3, HMGCR, KDR, PTGS2, SRC |
4.50921 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, MET, PIK3CA, PIK3CB, SRC |
4.47495 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
4.4235 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PPARA, PTGS1, PTGS2 |
4.38931 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TYR, XDH |
4.38918 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TYR, XDH |
4.36184 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, ESR1, HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
4.30196 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, HMGCR, HTR1A, TYR |
4.21738 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIK3CB, PIM1, SRC, TYR |
4.21207 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
4.1914 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, ALPL, AURKB, AXL, BCL2, CDC25B, CYP1A1, CYP1A2, DRD2, ESR1, FLT3, FUT7, GLO1, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
4.18179 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CYP1B1, DRD2, ESR1, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.18179 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, PTGS1, PTGS2 |
4.14852 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALPI, CYP19A1, CYP1A1, HMGCR, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.05882 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, EPHX2 |
4.04438 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EPHX2, PTGS1, PTGS2 |
4.00507 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
3.93502 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.922 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SRC |
3.86759 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.8526 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.84986 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.84986 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.84986 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
3.84225 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, DRD2, HMGCR, KDR, PIK3CB, PTGS2, SRC |
3.78173 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, EPHX2, FABP3, FLT3, HMGCR, PPARA, PTGS2, RORC, SRC |
3.78173 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, PPARA, PTGS1, PTGS2 |
3.7537 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.72323 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
3.68947 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, ESR1, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.66002 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DRD2, ESR1, PPARA, RORC, SRC, TOP2A |
3.58522 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, ESR1, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.56836 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HMGCR, HSD17B2, HTR1A |
3.55668 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
3.55225 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR |
3.52633 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
BCL2, CDC25B, DRD2, FABP3, FLT3, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.52633 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
BCL2, CDC25B, DRD2, FABP3, FLT3, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.52633 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, HTR1A, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC, TOP2A |
3.51484 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, DRD2, EPHX2, ESR1, FABP3, FABP4, MET, PIK3CA, PIK3CB |
3.50802 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
BCL2, CDC25B, DRD2, FLT3, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.50197 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AXL, BCL2, CA2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FLT3, HSD17B2, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR |
3.49106 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.45727 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, MET, PIK3CA, PIK3CB, SRC, XDH |
3.411 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.37211 |
[BP] GO:0042325 |
regulation of phosphorylation
|
BCL2, CDC25B, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.37211 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2 |
3.35616 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.34822 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.32698 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
BCL2, CDC25B, DRD2, FLT3, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.32413 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, HTR1A, TYR |
3.31544 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2 |
3.29718 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CYP1B1, DRD2, ESR1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
3.29718 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
BCL2, CDC25B, DRD2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.27122 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
BCL2, CDC25B, DRD2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.22733 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, BCL2, CYP1B1, DRD2, FABP4, FLT3, HMGCR, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.22037 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.212 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, APEX1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
3.20338 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CYP1A1, DRD2, ESR1, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MET, MMP2, MMP9, PTGS2, RORC, SRC, TOP2A |
3.20154 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
BCL2, CDC25B, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.19098 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.94691 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
2.94691 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD2, ESR1, FABP3, FABP4, GLO1, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
2.92467 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.91938 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
2.91938 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.90576 |
[BP] GO:0030334 |
regulation of cell migration
|
APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.90529 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
2.84773 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AURKB, BCL2, CDC25B, DRD2, EPHX2, ESR1, FABP3, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
2.84229 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AURKB, BCL2, CDC25B, DRD2, ESR1, FABP3, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
2.83602 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.83602 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
2.83602 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
AURKB, BCL2, CDC25B, DRD2, EPHX2, ESR1, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
2.80932 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.78031 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.78031 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.77748 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PTGS2, SRC |
2.732 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.732 |
[BP] GO:0016311 |
None
|
ALPI, ALPL, APEX1, BCL2, CDC25B, EPHX2, PTPN1 |
2.71546 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
2.70242 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.701 |
[BP] GO:2000145 |
regulation of cell motility
|
APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.69817 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALPI, DRD2, FABP3, FABP4, MET, PIK3CA, PIK3CB |
2.67258 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, HSD17B2, MMP2, MMP9, PTGS2, SRC, TOP2A |
2.67196 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC |
2.66386 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD2, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.65318 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.65318 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD2, HMGCR, MMP2, PPARA, PTGS2, SRC, TYR |
2.64631 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.63332 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.58934 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AURKB, BCL2, CDC25B, DRD2, ESR1, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
2.58914 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD2, FUT7, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.56763 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.56045 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
BCL2, CDC25B, DRD2, FLT3, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.55175 |
[BP] GO:0030154 |
cell differentiation
|
ALPL, AXL, BCL2, CYP1A1, ESR1, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MMP2, MMP9, PTGS2, RORC, TOP2A |
2.55103 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.54144 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.53637 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53637 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.524 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, KDR, SRC |
2.516 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HMGCR, PTGS2, SRC, TYR |
2.51089 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.50585 |
[BP] GO:0009987 |
cellular process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TYR, XDH |
2.50585 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, HMGCR |
2.50504 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.50504 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.49396 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2 |
2.46028 |
[BP] GO:0040012 |
regulation of locomotion
|
APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.44651 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
2.4429 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.43788 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, HMGCR, HTR1A, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC |
2.4348 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, PTGS2, SRC |
2.42142 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.42142 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.3925 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.3925 |
[BP] GO:0080134 |
regulation of response to stress
|
CYP19A1, DRD2, ESR1, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, XDH |
2.38769 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, HSD17B2, PTGS2, SRC |
2.35887 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, PIK3CB, PTGS2 |
2.35887 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD2, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.3558 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.35116 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35116 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, DRD2, ESR1, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, XDH |
2.34756 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, DRD2, ESR1, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, XDH |
2.33575 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CYP19A1, DRD2, ESR1, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.33069 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, HMGCR, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH |
2.33069 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, HMGCR, PTGS2 |
2.32348 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.30594 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, HMGCR, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH |
2.30407 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
2.29679 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, PPARA, PTGS2, SRC |
2.27027 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.26444 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD2, ESR1, FABP4, HMGCR, KDR, MET, MMP12, PPARA, PTGS2 |
2.23934 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, DRD2, ESR1, FABP4, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC |
2.22707 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.22528 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
CDC25B, DRD2, FABP4, FLT3, HMGCR, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
2.22196 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
BCL2, CDC25B, DRD2, ESR1, FLT3, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.21789 |
[BP] GO:0008217 |
None
|
DRD2, EPHX2, PPARA, PTGS1, PTGS2 |
2.21751 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.20774 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD2, ESR1, FABP3, FABP4, GLO1, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
2.19288 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC |
2.187 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.187 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.16033 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.1565 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, PTGS2, SRC |
2.1565 |
[BP] GO:0003018 |
None
|
EPHX2, HMGCR, HTR1A, PTGS2, SRC |
2.1565 |
[BP] GO:0031399 |
regulation of protein modification process
|
BCL2, CDC25B, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.1565 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.1327 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2 |
2.1327 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.12802 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.12723 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.12723 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
DRD2, FLT3, HMGCR, KDR, PIK3CB, PTPN1, SRC, XDH |
2.12186 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, PTGS2, TYR |
2.12186 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, HMGCR, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH |
2.11598 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, ESR1, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, XDH |
2.10358 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
IGF1R, PIK3CA, PIK3CB |
2.0968 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.0968 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.09519 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, EPHX2, ESR1, FABP3, PIK3CB |
2.0871 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.06211 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.06069 |
[BP] GO:0051338 |
regulation of transferase activity
|
AURKB, CDC25B, DRD2, FABP4, FLT3, HMGCR, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
2.06069 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2 |
2.04551 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, SRC |
2.0402 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.0402 |
[BP] GO:0043549 |
regulation of kinase activity
|
CDC25B, DRD2, FABP4, FLT3, HMGCR, IGF1R, PIK3CA, PIK3CB, PTPN1, SRC |
2.0278 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
BCL2, CDC25B, DRD2, ESR1, FLT3, HMGCR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.02568 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.00905 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.00073 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, KDR, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
2.2271 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.00905 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX5, ALPI, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TYR |
1.97657 |
[CC] GO:0005783 |
None
|
APEX1, BCL2, CA4, CYP19A1, FLT3, HMGCR, KDR, PTGS2, PTPN1, XDH |
1.74181 |
[CC] GO:0044425 |
membrane part
|
ACHE, ALPI, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FLT3, FUT7, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SRC, TYR |
1.73751 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, ALPI, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
12.629 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, FABP3, FABP4, FLT3, GLO1, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TYR, XDH |
12.2871 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FLT3, FUT7, GLO1, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
10.9317 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.5133 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPI, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, ESR1, GLO1, HTR1A, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, TOP2A, TYR, XDH |
8.37878 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.41586 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC |
7.36392 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.79188 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPI, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, TOP2A, TYR, XDH |
6.62422 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.22558 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.89049 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TOP2A |
5.14846 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC |
4.61234 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC |
4.4235 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR |
4.14852 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.89834 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, NQO2, PTGS1, PTGS2, SRC, XDH |
3.72953 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.72953 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.72208 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.29718 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.22037 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.02805 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, BCL2, DRD2, EPHX2, ESR1, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, NQO2, PTGS2, TOP2A, TYR, XDH |
2.99967 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.94691 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.91938 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.91072 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, BCL2, DRD2, EPHX2, FLT3, HMGCR, NQO2, PTGS2, TOP2A, TYR, XDH |
2.81416 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.78187 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.73573 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD17B2, XDH |
2.35887 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.23679 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, APEX1, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.20972 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.19167 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
2.13943 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.13583 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.0968 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, HMGCR, MET, PPARA, PTPN1 |
2.07365 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.00905 |
[MF] GO:0004035 |
alkaline phosphatase activity
|
ALPI, ALPL |
2.00905 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.00466 |